![]() |
L-R: Prof Karin Jandeleit-Dahm, Dr Stephen Gray and
Dr Jay Jha are researching inhibition of enzymes known to cause kidney injury in diabetes. See Diabetologia paper. Image: Life Scientist |
Diabetes affects around 1.7 million Australians. Sufferers with the disease are unable to control blood glucose levels either through failure to produce insulin (Type 1) or resistance of cells to insulin (Type 2). It can have a range of serious complications affecting the major arteries (macrovascular diseases) potentially leading to stroke, as well as causing kidney disease, nerve damage and loss of vision (microvascular diseases). The seriousness of these complications highlights the need for effective preventive measures.
In a collaborative study involving several Monash University researchers, a potential treatment was assessed and found to successfully reduce some of these complications.




